期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
靶向CCL21/CCR7轴治疗肿瘤转移的研究进展 被引量:1
1
作者 张莉 王发展 +3 位作者 姚晓含 马胜男 张利静 秦志海 《生物工程学报》 CAS CSCD 北大核心 2020年第12期2741-2754,共14页
转移是肿瘤患者死亡最常见的原因,而淋巴转移是大多数肿瘤转移的主要途径之一。近年来,CC趋化因子配体21(CC chemokine ligand 21,CCL21)及其受体CC趋化因子受体7型(CC chemokine receptor type 7,CCR7)在淋巴转移中的作用逐渐受到关注... 转移是肿瘤患者死亡最常见的原因,而淋巴转移是大多数肿瘤转移的主要途径之一。近年来,CC趋化因子配体21(CC chemokine ligand 21,CCL21)及其受体CC趋化因子受体7型(CC chemokine receptor type 7,CCR7)在淋巴转移中的作用逐渐受到关注。CCL21主要由淋巴内皮细胞产生,其与树突状细胞(Dendritic cells,DCs)和T细胞等表面CCR7的相互作用是免疫细胞淋巴迁移及淋巴结归巢的主要决定因素。然而,表达CCR7的肿瘤细胞也可以利用类似的机制进入淋巴管进行淋巴转移。如何靶向CCL21/CCR7轴,既能抑制淋巴转移,又不影响抗肿瘤免疫反应已成为肿瘤免疫治疗研究的重要议题。文中将对CCL21/CCR7轴在淋巴转移中的作用及其作为靶点治疗肿瘤转移的临床前和临床试验研究进行综述,为靶向CCL21/CCR7信号轴治疗肿瘤转移的相关研究提供参考。 展开更多
关键词 肿瘤 淋巴转移 CC 趋化因子配体21 CC 趋化因子受体7 靶向治疗
原文传递
Inhibiting collagen Ⅰ production and tumor cell colonization in the lung via miR-29a-3p loading of exosome-/liposome-based nanovesicles 被引量:10
2
作者 Yan Yan Cancan Du +10 位作者 Xixi Duan xiaohan yao Jiajia Wan Ziming Jiang Zhongyu Qin Wenqing Li Longze Pan Zhuoyu Gu Fazhan Wang Ming Wang Zhihai Qin 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2022年第2期939-951,共13页
The lung is one of the most common sites for cancer metastasis.Collagens in the lung provide a permissive microenvironment that supports the colonization and outgrowth of disseminated tumor cells.Therefore,down-regula... The lung is one of the most common sites for cancer metastasis.Collagens in the lung provide a permissive microenvironment that supports the colonization and outgrowth of disseminated tumor cells.Therefore,down-regulating the production of collagens may contribute to the inhibition of lung metastasis.It has been suggested that mi R-29 exhibits effective anti-fibrotic activity by negatively regulating the expression of collagens.Indeed,our clinical lung tumor data shows that mi R-29 a-3 p expression negatively correlates with collagen I expression in lung tumors and positively correlates with patients’outcomes.However,suitable carriers need to be selected to deliver this therapeutic mi RNA to the lungs.In this study,we found that the chemotherapy drug cisplatin facilitated mi R-29 a-3 p accumulation in the exosomes of lung tumor cells,and this type of exosomes exhibited a specific lung-targeting effect and promising collagen down-regulation.To scale up the preparation and simplify the delivery system,we designed a lung-targeting liposomal nanovesicle(by adjusting the molar ratio of DOTAP/cholesterol-mi RNAs to 4:1)to carry mi R-29 a-3 p and mimic the exosomes.This liposomal nanovesicle delivery system significantly down-regulated collagen I secretion by lung fibroblasts in vivo,thus alleviating the establishment of a pro-metastatic environment for circulating lung tumor cells. 展开更多
关键词 Lung metastasis miR-29a-3p CollagenⅠ Liposomal nanovesicle Exosomes Fibroblasts Pre-metastatic niche
原文传递
miR-130b inhibits proliferation and promotes differentiation in myocytes via targeting Sp1 被引量:2
3
作者 Yu-Cheng Wang xiaohan yao +12 位作者 Mei Ma Huihui Zhang Hui Wang Lei Zhao Shengnan Liu Chao Sun Peng Li Yuting Wu Xihua Li Jingjing Jiang Yuying Li Yan Li Hao Ying 《Journal of Molecular Cell Biology》 SCIE CAS CSCD 2021年第6期422-432,共11页
Muscle regeneration after damage or during myopathies requires a fine cooperation between myoblast proliferation and myogenic differentiation.A growing body of evidence suggests that microRNAs play critical roles in m... Muscle regeneration after damage or during myopathies requires a fine cooperation between myoblast proliferation and myogenic differentiation.A growing body of evidence suggests that microRNAs play critical roles in myocyte proliferation and differentiation transcriptionally.However,the molecular mechanisms underlying the orchestration are not fully understood.Here,we showed that miR-130b is able to repress myoblast proliferation and promote myogenic differentiation via targeting Sp1 transcription factor.Importantly,overexpression of miR-130b is capable of improving the recovery of damaged muscle in a freeze injury model.Moreover,miR-130b expression is declined in the muscle of muscular dystrophy patients.Thus,these results indicated that miR-130b may play a role in skeletal muscle regeneration and myopathy progression.Together,our findings suggest that the miR-130b/Sp1 axis may serve as a potential therapeutic target for the treatment of patients with muscle damage or severe myopathies. 展开更多
关键词 miR-130b muscle regeneration PROLIFERATION DIFFERENTIATION SP1
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部